152 related articles for article (PubMed ID: 6875848)
1. Pentobarbital causes cardiorespiratory depression by interacting with a GABAergic system at the ventral surface of the medulla.
Yamada KA; Moerschbaecher JM; Hamosh P; Gillis RA
J Pharmacol Exp Ther; 1983 Aug; 226(2):349-55. PubMed ID: 6875848
[TBL] [Abstract][Full Text] [Related]
2. Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
Gillis RA; Namath IJ; Easington C; Abrahams TP; Guidotti A; Quest JA; Hamosh P; Taveira da Silva AM
J Pharmacol Exp Ther; 1989 Feb; 248(2):863-70. PubMed ID: 2537419
[TBL] [Abstract][Full Text] [Related]
3. Comparative cardiorespiratory effects produced by taurine and glycine applied to the ventral surface of the medulla.
Gatti PJ; Souza JD; Namath IJ; Da Silva AM; Holtman JR; Gillis R
J Pharmacol Exp Ther; 1985 Dec; 235(3):820-8. PubMed ID: 3001279
[TBL] [Abstract][Full Text] [Related]
4. Cardiorespiratory effects produced by activation of cholinergic muscarinic receptors on the ventral surface of the medulla.
Gillis RA; Walton DP; Quest JA; Namath IJ; Hamosh P; Dretchen KL
J Pharmacol Exp Ther; 1988 Nov; 247(2):765-73. PubMed ID: 3183970
[TBL] [Abstract][Full Text] [Related]
5. Central gamma-aminobutyric acid involvement in blood pressure control.
Gillis RA; Yamada KA; DiMicco JA; Williford DJ; Segal SA; Hamosh P; Norman WP
Fed Proc; 1984 Jan; 43(1):32-8. PubMed ID: 6317463
[TBL] [Abstract][Full Text] [Related]
6. Gamma-aminobutyric acid type A receptor blockade at the intermediate area of the ventral surface of the medulla counteracts the cardiorespiratory depression produced by intravenous midazolam.
Taveira Da Silva AM; Pineo S; Gillis RA
Pharmacology; 1992; 45(3):154-61. PubMed ID: 1332084
[TBL] [Abstract][Full Text] [Related]
7. Medullary ventral surface GABA receptors affect respiratory and cardiovascular function.
Yamada KA; Norman WP; Hamosh P; Gillis RA
Brain Res; 1982 Sep; 248(1):71-8. PubMed ID: 6289995
[TBL] [Abstract][Full Text] [Related]
8. Ventrolateral medulla: an important site of action for the hypotensive effect of drugs that activate serotonin-1A receptors.
Mandal AK; Zhong PY; Kellar KJ; Gillis RA
J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S49-60. PubMed ID: 1702487
[TBL] [Abstract][Full Text] [Related]
9. Importance of central nervous system serotonin-1A receptors for mediating the hypotensive effect of urapidil.
Mandal AK; Kellar KJ; Friedman E; Pineo SV; Hamosh P; Gillis RA
J Pharmacol Exp Ther; 1989 Nov; 251(2):563-70. PubMed ID: 2530339
[TBL] [Abstract][Full Text] [Related]
10. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
Gillis RA; Hill KJ; Kirby JS; Quest JA; Hamosh P; Norman WP; Kellar KJ
J Pharmacol Exp Ther; 1989 Feb; 248(2):851-7. PubMed ID: 2521902
[TBL] [Abstract][Full Text] [Related]
11. Morphine, pentobarbital and naloxone in the ventral medullary chemosensitive areas: differential respiratory and cardiovascular effects.
Hurlé MA; Mediavilla A; Flórez J
J Pharmacol Exp Ther; 1982 Mar; 220(3):642-7. PubMed ID: 7062273
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of the respiratory action of pentobarbital at the medullary and pontine levels.
Hurlé MA; Dierssen MM; Flórez J
Eur J Pharmacol; 1986 Jun; 125(2):225-32. PubMed ID: 3017725
[TBL] [Abstract][Full Text] [Related]
13. Blockade of forebrain gamma-aminobutyric acid (GABA) receptors and reflex activation of the cardiac vagus in anesthetized cats.
DiMicco JA
J Pharmacol Exp Ther; 1982 Dec; 223(3):654-61. PubMed ID: 6292394
[TBL] [Abstract][Full Text] [Related]
14. Hypotensive effect of urapidil: CNS site and relative contribution.
Gillis RA; Dretchen KL; Namath I; Anastasi N; Dias Souza J; Hill K; Browne RK; Quest JA
J Cardiovasc Pharmacol; 1987 Jan; 9(1):103-9. PubMed ID: 2434784
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system site of action of capsaicin-induced cardiovascular changes in the cat.
Quest JA; Dias-Souza J; Norman WP; Holtman JR; Gillis RA
J Pharmacol Exp Ther; 1984 Mar; 228(3):719-24. PubMed ID: 6707921
[TBL] [Abstract][Full Text] [Related]
16. Activation of central nervous system cholecystokinin receptors stimulates respiration in the cat.
Gillis RA; Quest JA; Pagani FD; Souza JD; Da Silva AM; Jensen RT; Garvey TQ; Hamosh P
J Pharmacol Exp Ther; 1983 Feb; 224(2):408-14. PubMed ID: 6296361
[TBL] [Abstract][Full Text] [Related]
17. Cardiorespiratory alterations produced by pharmacological agents applied to the ventrolateral medulla (intermediate area) of the cat. Effect of exercise condition on glycine-induced inhibition.
Tolentino-Silva FP; Campos Júnior RR; Russo AK; Silva AC; Freire E; Guertzenstein PG
Braz J Med Biol Res; 1993 Aug; 26(8):879-96. PubMed ID: 7905329
[TBL] [Abstract][Full Text] [Related]
18. Microinjection of GABA antagonists into the posterior hypothalamus elicits locomotor activity and a cardiorespiratory activation.
Waldrop TG; Bauer RM; Iwamoto GA
Brain Res; 1988 Mar; 444(1):84-94. PubMed ID: 3129141
[TBL] [Abstract][Full Text] [Related]
19. The ventral surface of the medulla in the rat: pharmacologic and autoradiographic localization of GABA-induced cardiovascular effects.
Keeler JR; Shults CW; Chase TN; Helke CJ
Brain Res; 1984 Apr; 297(2):217-24. PubMed ID: 6326937
[TBL] [Abstract][Full Text] [Related]
20. Cardiorespiratory effects produced by injecting drugs that affect GABA receptors into nuclei associated with the ventral surface of the medulla.
Gatti PJ; DaSilva AM; Gillis RA
Neuropharmacology; 1987 May; 26(5):423-31. PubMed ID: 3037413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
